Printer Friendly 14,701,494 articles and books

Periodicals Literature Keyword Title Author Topic

Member login User name    Password    Remember me Join us Forgot password?

Submit articles free

Browse Drugs topic

Product development subtopic

Articles 1-96 out of 96 article(s) Title Author Type Date Words ' Patient safety first during drug trials'. Dec 4, 2009 461 pSivida Announces Last Patient in Phase III Iluvien[R] Trial Completes 2 Year Follow-Up Visit. Oct 14, 2009 804 Omnia Biologics and AparnaBio Sign Lentivirus Drug Development Agreement. Aug 18, 2009 232 Research and Markets: Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medicines. Jun 30, 2009 476 Atox Bio and Fast-Track Drugs & Biologics Sign an R&D Collaboration Agreement for the Development of Therapeutics for Sepsis and Septic Shock. Jun 24, 2009 799 A.P. Pharma Presents APF530 Phase 3 Data at Annual Meeting of the American Society of Clinical Oncology. Clinical report Jun 1, 2009 1018 Allos Therapeutics Announces FDA Accepts Pralatrexate NDA for Filing and Grants the Application Priority Review Status. May 26, 2009 1128 APF530 Phase 3 Data for Chemotherapy-Induced Nausea and Vomiting to be Presented at American Society of Clinical Oncology 2009 Annual Meeting. May 18, 2009 690 pSivida Corp. Reports Iluvien[TM] Phase III Studies for DME Pass Final DSMB Review Prior to October Readout. Apr 8, 2009 940 Governor, Legislature Support Sales Tax Exemptions For Clinical Trials and Free Samples of Drugs. Apr 8, 2009 446 Technology & life sciences. Brief article Apr 6, 2009 123 Institute of Microbiology of the Chinese Academy of Sciences and TB Alliance Announce Partnership to Develop New Tuberculosis Drugs from Natural Sources. Mar 31, 2009 1313 Halozyme Begins Phase 1 Clinical Study with PEGPH20 in Cancer Patients with Refractory Solid Tumors. Mar 31, 2009 750 Trials of 11 drugs give best hope yet of treatment for Alzheimer's. Mar 19, 2009 339 Merck & Co., Inc. Donates Antimalarial Candidate to Medicines for Malaria Venture for Use in Developing World. Mar 18, 2009 854 pSivida Corp: Enrollment complete in BrachySil[TM] Dose Ranging Study. Mar 4, 2009 783 CPEX Pharmaceuticals Announces Completion of Phase 2 Trial for Urology Drug by Serenity Pharmaceuticals. Feb 26, 2009 551 BioDelivery Sciences Announces Initial Results of Phase 1 Clinical Study of Bioral Amphotericin B. Feb 5, 2009 925 PII and NexMed Enter into Strategic Collaboration Agreement for NexMed's NexACT[R] Drug Delivery Platform. Jan 22, 2009 503 MacuCLEAR and Mystic Pharmaceuticals Agree To Collaborate on Macular Degeneration Phase I/II Clinical Trial. Jan 13, 2009 457 Change as constant: why pharma companies should act now in anticipation of regulatory changes: within 10 years, reporting will be risk-based across a broad spectrum of products, and pharmacovigilance procedures will be an integral part of a product's development plan. companies must anticipate [this] and build the foundation for processes that easily accommodate change. Jan 1, 2009 1104 Vitronic sets drug production safety standards. Jan 1, 2009 366 Many drug trials never published; results are often biased, incomplete or unavailable. Ehrenberg, Rachel Dec 20, 2008 720 pSivida New Clinical Trial for Drug Delivery Device in AMD. Dec 11, 2008 816 CPEX Pharmaceuticals Announces Initiation of Phase II Trial for Urology Indication by Serenity Pharmaceuticals. Nov 17, 2008 510 Global Alliance for TB Drug Development Receives Pledge of up to $40 Million from USAID. Oct 13, 2008 515 United States : DFID announces call for applications for new product development partnerships for drugs and vaccines. Oct 9, 2008 141 Antares Pharma Enters Into a Feasibility Development Agreement with Dr. Reddy's Laboratories, Inc. for an Enhanced Dermatology Product Utilizing the ATD Gel Platform. Sep 3, 2008 793 Amgen recovering nicely from anemia drug woes. Kareem, Nadra Sep 1, 2008 1015 Enrollment in Phase IIb Clinical Trial for I-vation(TM) TA (MK-0140) Suspended Pending Review of Study Design by Merck & Co., Inc. Aug 8, 2008 720 SurModics Announces Initiation by Merck & Co., Inc. of Phase IIb Clinical Trial for I-vation(TM) TA. Jun 25, 2008 672 Data from Phase II Exploratory Study Suggest That ORENCIA(R) (abatacept) May Delay Development of Rheumatoid Arthritis in Adults with Undifferentiated Inflammatory Arthritis. Clinical report Jun 13, 2008 2154 Find out Which Companies Are Co-Developing Drugs and Diagnostic Products with Innovative Clinical Trial Design and Management. Jun 12, 2008 863 Tioga's treatment for digestive disorders shows promise in tests. Chambers, Heather Jun 2, 2008 312 Calando Receives FDA Approval for Phase I Clinical Trial Using a Targeted siRNA Nanoparticle Therapeutic. Apr 21, 2008 818 SurModics Announces First Human Use of SynBiosys(TM) Biodegradable Polymer on CardioMind Drug-Eluting Stent. Mar 31, 2008 1157 'Icy Fire' drug developed at UC San Diego might be first of its kind. Chambers, Heather Brief article Mar 17, 2008 175 GENEREX GETS APPROVAL FOR ORAL-LYN PHASE III TRIAL. Mar 1, 2008 453 Depomed Reports Positive Efficacy Data From a Phase 2 Trial of Gabapentin GR(TM) in the Treatment of Menopausal Hot Flashes. Medical condition overview Feb 12, 2008 1501 Unigene Initiates Phase I/II Clinical Study for Oral Calcitonin. Feb 11, 2008 587 Time to change: NostraPharmus predicts that a more strategic and proactive approach to safety will win back consumer confidence. Jan 1, 2008 749 In brief ... Dec 1, 2007 358 Agreements. Dec 1, 2007 784 TB Alliance Advances Two Drugs in Clinical Trials on Path to Faster, Better Tuberculosis Treatments. Nov 8, 2007 1387 GTx, Inc. and Merck & Co., Inc. Enter Global Strategic Collaboration for the Development of SARMs, a Novel Investigational Class of Drugs to Treat Muscle Loss and other Musculoskeletal Conditions. Nov 6, 2007 1521 A chemist's progress. Gihani, Moharem El Sep 1, 2007 1669 Label-free screening of small molecular weight drugs: bringing new drugs to market is an expensive and time-consuming process, and even with HTS processes, has a high attrition rate. Hovever, there are systems that have been developed to help improve the process by providing real-time analysis of parameters such as binding specificity, affinity and kinetics. Sep 1, 2007 989 NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product. Jul 9, 2007 278 A.P. Pharma Clarifies Effective Date of Reverse Stock Split. May 24, 2007 347 SurModics Signs Agreement with St. Jude Medical. Apr 12, 2007 395 Preclinical Data on Cytogen's Technology to be Reported at the AACR Annual Meeting. Mar 29, 2007 949 SCOLR Pharma Announces Research Collaboration with BioCryst Pharmaceuticals. Mar 9, 2007 970 The Medicines Company's Cleviprex(TM) (Clevidipine) Phase III Safety Trials Meet Pre-Specified Objectives. Jan 9, 2007 586 Ipsen: Initiation of Phase III Clinical Trials with Decapeptyl(R)'s 4-Month Sustained Release Formulation. Dec 14, 2006 730 InSite Vision Announces Initiation of a Phase 1 Safety Trial on AzaSite Plus(TM). Nov 8, 2006 889 More data requested. Crowe, Deborah Brief article Oct 23, 2006 122 Inspire Begins Phase 2 Clinical Program of Epinastine for Seasonal Allergic Rhinitis. Oct 10, 2006 575 The Medicines Company Commences Phase III Clinical Trial of Cangrelor. Clinical report Oct 4, 2006 682 Acrux to Start USA Trial of Its Unique Testosterone Lotion For Men. Sep 18, 2006 737 The Medicines Company Completes Clevidipine Phase III Safety Trials and Initiates Phase III Severe Hypertension Trial; ECLIPSE Enrollment Complete, First Patient Enrolled in VELOCITY. Sep 11, 2006 737 Science Takes Aim at Elders' Frailty. Sep 1, 2006 500 Nektar Closes Its Bradford UK Site; Company Focusing on Development of Products Using its Drug Delivery Technology. Jul 26, 2006 691 Drug companies gain from BioShield II. Lawrence, Marta Jun 1, 2006 725 Experimental AD drugs target nicotinic receptors. Sullivan, Michele G. May 1, 2006 1013 A.P. Pharma Initiates APF530 Phase 3 Clinical Trial; IRB Approval Received. Apr 27, 2006 668 Calando Pharmaceuticals Establishes Research Collaboration with National Cancer Institute to Develop RNAi Therapeutics; Cooperative Research and Development Agreement (CRADA) to Focus on RNAi Therapeutics -- to Target Neuroblastoma. Feb 3, 2006 696 SurModics and Donaldson Company Announce Introduction of the First Jointly Developed Nanofiber Cell Culture Product; New Synthetic ECM Mimics 3-D Cell Growth in Body. Jan 30, 2006 1258 SAS Helps Executives at Aeris Therapeutics Breathe Easier; Biopharmaceutical Firm Selects SAS(R) For Business Intelligence (BI) To Navigate the Clinical Trial Approval Process. Jan 23, 2006 533 Inspire Discontinues Retinal Disease Drug Development Program. Jan 20, 2006 530 AVI BioPharma Reports Favorable Safety and Pharmacokinetic Data From Its Clinical Trial Targeting Hepatitis C Virus; NEUGENE Antisense Compound Was Well-Tolerated and Exhibited Favorable Pharmacokinetic Parameters. Jan 10, 2006 1038 High-performance R&D, delivered. Brief Article Dec 1, 2005 103 Inhibiton Therapeutics Completes First Year of Collaborative Work under Cooperative Research and Development Agreement (CRADA). Nov 28, 2005 556 Chiron and XOMA Announce Initiation of Phase I Clinical Trial for CHIR-12.12 in Multiple Myeloma -- Second Clinical Trial Evaluating Oncology Drug Candidate Begins. Oct 13, 2005 1230 Mack and Transport Pharmaceuticals Announce Development Agreement for Breakthrough Cold Sore Product; Innovative Device/Drug Combination System Currently in Phase III Trials. Oct 12, 2005 839 MannKind takes its shots in insulin race. Myerhoff, Matt Jul 25, 2005 960 Pharmaceutical. Brief Article Jun 15, 2005 164 Global Pharmatech obtains patent purification methodologies of echinocystic acid. Jun 1, 2005 387 An overview of the drug development process. Tonkens, Ross May 1, 2005 1598 The race to prescribe: drug for African Americans may debut amid debate. Harder, Ben Apr 16, 2005 1938 Genaissance allowed patent for method of testing individuals for genetic predisposition to reduced metabolism of drugs. Mar 1, 2005 473 Plant protein may play role in human health. Brief Article Feb 14, 2005 283 Voluntary clinical trials registration sought. Lesney, Mark S. Feb 1, 2005 1246 King and Palatin form strategic alliance to jointly develop and commercialize PT-141 as an innovative treatment for sexual dysfunction. Aug 1, 2004 1252 Lexicon Genetics and Takeda establish collaboration to develop new drugs for high blood pressure. Jul 1, 2004 639 QUESTIONS AND ANSWERS ON NRLC'S OPPOSITION TO DRUG PRICE CONTROLS. Jun 1, 2004 2460 NPS Pharmaceuticals Inc. Brief Article Jun 1, 2004 35 Labor pool attracts biotech firm to NJ. Brief Article Apr 28, 2004 258 Drug development in the United States; featured CME topic: southern medical journal. Moore, Sharon Wyatt Dec 1, 2003 585 American Pharmaceutical Partners Inc. Brief Article Sep 29, 2003 78 Mollusks point way toward better drugs. Brief Article Sep 27, 2003 263 Drugstore cowboys. Sep 1, 2003 363 Buckymedicine: coming soon to a pharmacy near you? Gorman, Jessica Jul 13, 2002 1896 The challenges of data management in biotech: booming life sciences research has IT resources bursting at the seams. (Storage Networking). Chudnow, Christine Taylor Industry Overview Jul 1, 2002 2811 Making well people "better". (The Risks of the Rush). Mooney, Pat Jul 1, 2002 2260 Isis starts clinical trials for hepatitis C drug. (Biotech). Webb, Marion Brief Article Apr 1, 2002 202 More drugs in development for pediatric use. Apr 1, 1998 761

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles